Recent advances in the discovery and development of quinolones and analogs as antitumor agents

Current Medicinal Chemistry

Volumn 6, Issue 3, 1999, Pages 179-194

  Xia, Yi ^a   Yang, Zheng Yu ^a   Morris Natschke, Susan L ^a   Lee, Kuo Hsiung ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A 65281; A 65282; A 83669; A 84441; ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT; BICYCLO COMPOUND; BO 2367; BO 2637; CIPROFLOXACIN; COLCHICINE; CP 115953; CP 115955; CP 67804; DR 3255; FLAVONOL; FLEROXACIN; GYRASE INHIBITOR; LEVOFLOXACIN; NATURAL PRODUCT; NORFLOXACIN; OFLOXACIN; PODOPHYLLOTOXIN; QUINAZOLINE DERIVATIVE; QUINOLONE DERIVATIVE; REFLOXACIN; ROSOXACIN; TRICYCLIC AROMATIC COMPOUND; UNCLASSIFIED DRUG; WIN 57294; WIN 58161;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; CHEMICAL MODIFICATION; CHIRALITY; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; DNA TOPOISOMERASES, TYPE II; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HUMANS; QUINOLONES; TUMOR CELLS, CULTURED;

EID: 0032903696     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Lee, K. H. Antitumor Agents 188. Highlights of Research on Plant-Derived Natural Products and Their Analogs with Antitumor, Anti-HIV, and Antifungal Activity," in S. J. Cutler and H. G. Cutler Eds. "Biologically Active Natural Products: Agrochemicals and Pharmaceuticals." Amer. Chem. Soc. Symposium Series, ACS Washington, DC, in press.
2. Dax, S. L. Antibacterial Chemotherapeutic Agents, Blackie Academic & Professional, London
3. Piddock, L. J. V. New Quinolones and Gram-positive Bacteria. Antimicrobial, Agents and Chemotherapy, 1994, 39, 163-169.
4. Shen, L. L. Molecular Mechanism of DNA Gyrase Inhibition by Quinolone Antibacterials. Advan. in Pharm, 1994, 29A, 285-304.
5. Shen, L. L.; Mitschel, L. A.; Sharma, P. N.; O'Donnel, T. J.; Cheu, D. W. Cooper, C. S.; Rosen, T.; Pernet, A. G. Mechanism of Inhibition of DNA Gyrase by Quinolone Antibacterials: A Cooperative Drug-DNA Binding Model. Biochemistry, 1989, 28, 3886-3894.
6. Suto, M. J.; Domagala, J. M.; Roland, G. E.; Mailloux, G. B.; Cohen, M. A. Fluoroquinolones: Relationships Between Structural Variations, Mammalian Cell Cytotoxicity, and Antimicrobial Activity. J. Med. Chem. 1992, 35, 4745-4750.
7. Liu, L. F. DNA Topoisomerase Poisons as Antitumor Drugs. Annu. Rev. Biochem. 1989, 58, 351-375.
8. Wang, J. C. DNA Topoisomerases. Annul Rev. Biochem. 1985, 54, 665-697.
9. Maxwell, A.; Gellert, M. Mechanistic Aspects of DNA Topoisomerases. Adv. Protein Chem. 1986, 38, 69-107.
10. Wang, H. K.; Morris-Natschke, S. L.; Lee, K. H. Recent Advances in the Discovery and Development of Topoisomerase Inhibitors as Antitumor Agents. Med. Res. Rev. 1997, 17, 367-425.
11. Hoshino, K.; Sato, K.; Une, T.; Osada, Y. Inhibitory Effects of Quinolones on DNA Gyrase of Escherichia coli and Topoisomerase II of Fetal Calf Thymus. Antimicrobial Agents & Chemotherapy 1989, 33, 1816-1818.
12. Hussy, P.; Maass, G.; Tummler, B.; Grosse, F.; Schomburg, U. Effect of 4-Quinolones and Novobiocin on Calf thymus DNA Polymerase alpha Primase Complex, Topoisomerases I and 11, and Growth of Mammalian Lymphoblasts. Antimicrobial Agents & Chemotherapy1986, 29, 1073-1078.
13. Lynn, R.; Giaever, G.; Swanberg, S. L.; Wang, J. C. Tandem Regions of Yeast DNA Topoisomerase II Share Homology with Different Subunits of Bacterial Gyrase. Science 1986, 233, 647-649.
14. Uemura, T.; Morikawa, K.; Yanagida, M. The Nucleotide Sequence of the Fission Yeast DNA Topoisomerase II Gene: Structural and Functional Relationships to Other DNA Topoisomerases. EMBO Journal 1986, 5, 2355-2361.
15. Yamashita, Y.; Ashizawa, T.; Morimoto, M.; Hosomi, J.; Nakano, H. Antitumor Quinolones with Mammalian Topoisomerase II Mediated DNA Cleavage Activity. Cancer Research. 1992, 52, 2818-2822.
16. Wentland, M. P.; Cornett, J. B.; Quinolone Antibacterial Agents. Annu. Rep. Med. Chem. 1985, 20, 145-154.
17. Wentland, M. P.; Iesher, G. Y.; Reuman, M.; Gruett, M. D.; Singh, B.; Aldous, S. C.; Dorff, P. H.; Rake, J. B.; Coughlin, S. A. Mammalian Topoisomerase II inhibitory Activity of 1-Cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-qu inolinecarboxyl ic Acid and Related Derivatives. J. Med. Chem. 1993, 36, 2801-2809.
18. Robinson, M. J.; Martin, B. A.; Gootz, T. D.; McGuirk, P. R.; Moynihan, M.; Sutcliffe, J. A.; Osheroff, N. Effects of Quinolone Derivatives on Eukaryotic Topoisomerase II. A Novel Mechanism for Enhancement of Enzymemediated DNA Cleavage. J. Biol. Chem. 1991, 266, 14585-14592.
19. Robinson, M. J.; Martin, B. A.; Gootz, T. D.; McGuirk, P. R.; Osheroff, N. Effects of Novel Fluoroquinolones on the Catalytic Activities of Eukaryotic Topoisomerase II: Influence of the C-8 Fluorine Group. Antimicrobial Agents & Chemotherapy 1992, 36, 751-756.
20. KUO, G. H.; Eissenstat, M. A. Potent Mammalian Topoisomerase II Inhibitors:1-Cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)- 4-substituted- quinolones. Bioorg. Med. Chem. Lett. 1995, 5, 399-404.
21. Eissenstat, M. A. 3-Benzyl-quinolones: Novel, Potent Inhibitors of Mammalian Topoisomerase II Bioorg. Med. Chem. Lett. 1995, 5, 1021-1026.
22. William, E. K.; Kohlbrenner, W. E.; Wideburg, N.; Weigl, D.; Saldiver, A.; Chu, D. T. Induction of Calf thymus Topoisomerase II-mediated DNA Breakage by the Antibacterial Isothiazoloquinolones A-65281 and A-65282. Antimicrobial Agents & Chemotherapy 1992, 36, 81-86.
23. Chu, D. T.; Fernancles, P. B. Recent Development in the Field of Quinolone Antibacterial Agents. Advances in Drug Research 1991, 21, 39-144.
24. Wentland, M. P.; Aldous, S. C.; Gruett, M. D.; Perni, R. B.; Powles, R. G.; Danz, D. W.; Klingbeil, K. M.; Peverly, A. D.; Robinson, R. G.; Corbett, T. H.; Rake, J. B.; Coughlin, S. A. The Antitumor Activity of Novel Pyrazoloquinoline Derivatives. Bioorg. Med. Chem. Lett. 1995, 5, 405-410.
25. Chu, D. T.; Hallas, R.; Clement, J. J.; Alder, J.; McDonald, E.; Plattner, J. J. Synthesis and Antitumour Activities of Quinolone Antineoplastic Agents. Drugs Exper. Clin. Res. 1992, 18, 275-282.
26. Clement, J. J.; Burres, N.; Jarvis, K.; Chu, D. T.; Swiniarski, J.; Alder, J. Biological Characterization of a Novel Antitumor Quinolone. Cancer Research 1995, 55, 830-835.
27. Permana, P. A.; Snapka, R. M.; Shen, L. L.; Chu, D. T.; Clement, J. J.; Platter, J. J. Quinobenoxazines: a Class of Novel Antitumor Quinolones and Potent Mammalian DNA Topoisomerase II Catalytic Inhibitors. Biochemistry1994, 33, 11333-11339.
28. Atarashi, S.; Yokohama, S.; Yamazaki, K.; Sakano, K.; Imamura, M.; Hayakawa, I. Synthesis and Antibacterial Activities of Optically Active Ofloxacin and Its Fluoromethyl Derivative. Chem. Pharm. Bull. 1987, 35, 1896-1902.
29. Yashinari, T.; Mano, E.; Arakawa, H.; Kurama, M.; Iguch, T.; Nakagawa, S.; Tanaka, N.; Okura, A. Stereo(C7)-dependent Topoisomerase II inhibition and Tumor Growth Suppression by a New Quinolone, BO-2367. Jpn. J. Cancer Res., 1993, 84, 804-804.
30. Cooughlin, S. A.; Danz, D. W.; Robinson, R. G.; Klingbeil, K. M.; Wentland M.; Corbett, T. H.; Waud, W. R.; Zwelling, L. A.; Altschuler, E.; Bales, E.; Bake, J. B. Mechanism of Action and Antitumor Activity of (s)-10-(2,6-Dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7-h- pyrido[1,2,3de]-[1,4]benzoethiazine-6- carboxylic Acid (WIN 58161). Biochem. Pharm. 1995, 50, 111-122.
31. Kuo, S. C.; Lee, H. Z.; Juang, J. P.; Lin, Y. T.; Wu, T. S.; Chang, J. J.; Lednicer, D.; Paull, K. D.; Lin, C. M.; Hamel, E. Synthesis and Cytotoxicity of 1,6,7,8-Substituted 2-(4′-substituted phenyl)-4-quinolones and Related Compounds: Identification as Antimitotic Agents Interacting with Tubulin J. Med. Chem. 1993, 36, 1146-1156.
32. Li, L.; Wang, H. K.; Kuo, S. C.; Wu, T. S.; Lednicer, D.; Lin, C. M.; Hamel, E.; Lee, K. H. Antitumor Agents. 150. 2′,3′,4′,5′,5,6,7-Substituted 2-Phenyl-4-quinolones and Related Compounds: Their Synthesis, Cytotoxicity, and Inhibition of Tubulin Polymerization. J. Med. Chem. 1994, 37, 1126-1135.
33. Li, L.; Wang, H. K.; Kuo, S. C.; Wu, T. S.; Mauger, A.; Lin, C. M.; Hamel, E. Lee, K. H. Antitumor Agents.155. Synthesis and Biological Evaluation of 3′,6,7-Substituted 2- Phenyl-4-quinolones as Antimicrotubule Agents. J. Med. Chem. 1994, 37, 3400-3407.
34. Edelman, G. Surface Modulation in Cell Recognition and Cell Growth. Science 1976, 192, 218-226.
35. Dustin, P. Microtubules. Sci. Am. 1980, 243, 66-76.
36. Crossin, K. L.; Carney, D. H. Evidence that Microtubule Depolymerization Early in the Cell Cycle is Sufficient to Initiate DNA Synthesis. Cell 1991, 23, 61-71.
37. Otto, A. M.; Ulrich, M. O.; Zumbe, A.; De Asua, L. J. Cytoskeletal-disrupting Drugs Enhance Effects of Growth Factors and Hormones on Initiation of DNA Synthesis. Proc. Nat. Acad. Sci. U. S. A. 1981, 76, 6435-6438.
38. Wordenman, L.; Mitchison, T. J. Dynamics of Microtubules Assembly in vivo. In Microtubules, Hyams, J. S.; Lloyd, C. W.; Wiley-Liss, In., New York, 1994, pp 287-301.
39. Chu, D. T.; Fernandes, P. B.; Maleczka, R.; Nordeen, C. W.; Pernet, A. G. Synthesis and Structure-activity Relationship of 1-Aryl-6,8-difluoroquinolone Antibacterial Agents. J. Med. Chem. 1987, 30, 504-509,
40. Cheng, C. C. A Common Structure Pattern Among Many Biologically Active Compounds of Natural and Synthetic Origin. Med. Hypotheses 1986, 20, 157-172.
41. Lee, K. H.; Tagahara, K.; Suzuki, H.; Wu, R. Y.; Haruna, M.; Hall, IIH.; Huang, H. C.; Ito, K.; Iida, T.; Lai, J. S. Antitumor Agents 49. Tiricin, Kaempferol 3-O-β-D-glycopyranoside and (+)-Nortrachelogenin, Antileukemic Principles from Wilstroemia indica. J. Nat. Prod. 1981, 44, 530-535.
42. Huang, M. T.; Wood, A. W.; Newmark, H. L.; Sayer, J. M.; Yagi, H.; Jerina, D. M.; Conney, A. H. Inhibition of the Mutagenicity of Bay-Region Diol Epoxides of Polycyclic Aromatic Hydrocarbons by Phenolic Plant Flavonoids. Carcinogenesis 1983, 4, 1631-1637.
43. Wattenbery, L. W.; Leong, J. L. Inhibition of the Carcinogenic Action of 7,12-Dimethylbenz [a] anthracene by Beta-Naphthoflavone. Proc. Soc. Exptl. Biol. Med. 1968, 128, 940-943.
44. Shi, Q.; Chen, K.; Li, L.; Chang, J. J.; Autry, C.; Kozuka, M.; Konoshima, T.; Estes, J. R.; Lin, C. M.; Hamel, E.; McPhail, A. T.; McPhail, D. R.; Lee, K. H. Antitumor Agents. 154. Cytotoxic and Antimitotic Flavonols from Polanisia dodecandra. J. Nat. Prod. 1995, 50, 475-482.
45. Paull, KD, Shoemaker, R. H.; Hodes, L.; Monks, A.; Scudiero, D. A.; Rubinstein, L.; Plowman, J.; Boyd, M. R. Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm. J. Natl. Cancer Inst. 1909, 81, 1088-1092.
46. Paull, K. D.; Hamel, E.; Malspeis, L. Predicition of Biochemical Mechanism of Action from the in vitro Antitumor Screen of the National Cancer institute. In: Cancer Chemotherapeutic Agents (Ed. Foye WO), pp 9-45 American Chemical Society Washington, DC, 1995.
47. Hamel, E.; Ho, H. H.; Kang, G. J.; Lin, C. M. Cornigerine, a Potent Antimitotic Colchicum Alkaloid of Unusual Structure. Interactions with Tubulin. Biochem. Pharm. 1988, 37, 2445-2449.
48. Kelly, M.; Hartwell, J. The Biological Effects and the Chemical Composition of Podophyllin. A review. J. Natl. Cancer Inst. 1954, 14,967-1010.
49. Wang, R. W.; Rebhun, L. I.; Kupchan, S. M. Antimitotic and Antitubulin Activity of the Tumor Inhibitor Steganacin. Cancer Res. 1977, 37, 3071-3079.
50. Lin, C. M.; Ho, H. H.; Pettit, G. R.; Hamel, E. Antimitotic Natural Products Combretastatin A-4 and Combrelastatin A-2: Studies on the Mechanism of Their Inhibition of Binding of Colchicine to Tubulin. Biochemistry 1989, 28, 6984-6991.
51. Chen, K.; Kuo, S. C.; Hsieh, M.; Mauger, A.; Lin, C. M.; Hamel, E.; Lee, K. H. Antitumor Agents.174. 2′,3′,4′,5,6,7-Substituted 2-Phenyl-1,8-naphthyridin-4-ones: Their Synthesis, Cytotoxicity, and Inhibition of Tubulin Polymerization. J. Med. Chem. 1997, 40, 2266-2275.
52. Chen, K.; Kuo, S. C.; Hsieh, M.; Mauger, A.; Lin, C. M.; Hamel, E.; Lee, K. H. Antitumor Agents.178. Synthesis and Biological Evaluation of 2-Aryl-1,8naphthyridin-4(1 H)-ones as Antitumor Agents that Inhibit Tubulin Polymerization. J. Med. Chem. 1997, 40, 3049-3056.
53. Yale, H. J.; Kalkstein, M. Substituted 2,3-Dihydro-4(1H)-quinazolinones. A New Class of inhibitors of Cell Multiplication. J. Med. Chem. 1967, 10, 334-336.
54. Neil, G. L.; Li, L. H.; Buskirk, H. H.; Moxley, T. E. Antitumor Effects of the Antispermatogenic Agent, 2,3-Dihydro-2-(1-naphthyl)-4(1 H)-quinazolinone. Cancer Chemother. 1972, 56, 163-173.
55. Hamel, E.; Lin, C. M.; Plowman, J.; Wang, H. K.; Lee, K. H.; Paull, K. D. Antitumor 2,3- Dihydro-2-(aryl)-4(1 H)-quinazolinone Derivatives. Interactions with Tubulin. Biochem. Pharmacol. 1996, 51, 53-59.
56. Jiang, J. B.; Hesson, D. P.; Dusak, B. A.; Dexter, D. L.; Kang, G. J.; Hamel, E. Synthesis and Biological Evaluation of 2-Styrylquinazolin-4(3H)-ones, a New Class of Antimitotic Anticancer Agents which Inhibit Tubulin Polymerization. J. Med. Chem. 1990, 33, 1721-1728.
57. Lin, C. M.; Kang, G. J.; Roach, M. C.; Jiang, J. B.; Hesson, D. P.; Luduena, R. F.; Hamel, E. Investigation of the Mechanism of the Interaction of Tubulin with Derivatives of 2-Styrylquinazolin-4(3H)-one. Mol. Pharmacol. 1991, 40, 827-832.
58. Buetler, J. A.; Cardellina, J. H.; Lin, C. M.; Hamel, E.; Cragg, G. M.; Boyd, M. R. Centaureidin, a Cytotoxic Flavone from Polymnia fruticosa Inhibits Tubulin Polymerization. Bioorg. Med. Chem. Lett. 1993, 3, 581-584.
59. Lichius, J. J.; Thoison, O.; Montagnac, A.; Pais, M.; Gueritte-Voegelein, F.; Sevenet, T. Antimitotic and Cytotoxic Flavonols from Zieridium pseudobtusifolium and Acronychia porteri J. Nat. Prod. 1994, 57, 1012-1016.
60. Shi, Q.; Verdier-Pinard, P., Brossi, A.; Hamel, E.; McPhail, A. T.; Lee, K. H. Antitumor Agents. 172. Synthesis and Biological Evaluation of Novel Deacetamidothiocolchicin-7-ols and Ester Analogs as Antitubulin Agents. J Med. Chem. 1997, 40, 961-966.
61. Hastie, S. B. Interactions of Colchicine with Tubulin. Pharm. & Ther. 1991, 51, 377-401.
62. Brossi, A.; Yeh, H. J.; Chrzanowska, M.; Wolff, J.; Hamel, E.; Lin, C. M.; Quinn, F.; Suffness, M.; Silverton, J. Colchicine and Its Analogues: Recent Findings. Med. Res. Rev. 1988, 8, 77-94.
63. Xia, Y.; Yang, Z. Y.; Xia, P.; Bastow, K.; Tachibana, Y.; Kuo, S. C.; Hamel, E.; Hackl, T.; Lee, K. H. Antitumor Agents 181, Synthesis and Biological Evaluation of 6,7,2′,3′,4′-Substituted-1,2,3,4-tetrahydro-2-phenyl- 4quinolones as a New Class of Antimitotic Antitumor Agents. J. Med. Chem. 1998, 41, 1155-1162.